Bacillus anthracis R/D BATERIOPHAGE STRAIN USED TO PRODUCE PREPARATION FOR ANTHRAX INFECTION DIAGNOSTICS, LIQUID PREPARATION FOR ANTHRAX INFECTION DIAGNOSTICS AND PREPARATION FOR ANTHRAX INFECTION DIAGNOSTICS Russian patent published in 2009 - IPC C12N7/00 A61K35/76 

FIELD: chemistry, biochemistry.

SUBSTANCE: group of inventions concerns medical virology and microbiology. Bacillus anthracis R/D bacteriophage strain, deposited in collections of microorganism museum of State Research Centre of Applied Microbiology Practical Molecular Biology under serial number Ph-6, is used to produce preparation for anthrax infection diagnostics. Liquid preparation for anthrax infection diagnostics contains suspended particles of bacteriophage Bacillus anthracis R/D-Ph-6 of lytic activity 10¹⁰ plaque-forming unit/cm³, 1% quinosol solution, in ratio as follows, wt %: suspended bacteriophage of lytic activity 10¹⁰ plaque-forming unit/ml - 10.0-20.0, 1% quinosol solution - 0.5-1.0, physiologic saline - the rest. Dry preparation for anthrax infection diagnostics contains dry solid matter of bacteriophage Bacillus anthracis R/D-Ph-6 of lytic activity 10¹⁰ plaque-forming unit/cm³, saccharose, gelatine and quinosol in ratio as follows, wt %: saccharose - 35.0-40.0, gelatine - 6.0-10.0, quinosol - 0.03-0.06, dry solid matter of bacteriophage of lytic activity 10¹⁰ plaque-forming unit/cm³ - the rest.

EFFECT: implemented fast identification of anthrax agent for effective medical and antiepidemic actions.

3 cl, 1 tbl, 9 ex, 1 dwg